Posted by john on June 27th, 2006 — in Nexium Top News
Smokers are about to get some radically different methods to help them quit, based in large part on scientists’ progress in attacking nicotine addiction where it happens: in the smoker’s brain.
Last week, patients in a clinical trial at Massachusetts General Hospital received their first doses of an experimental vaccine that keeps most nicotine from […]
No Comments »
Posted by john on June 26th, 2006 — in Nexium Top News
Vermont on Monday began requiring Medicaid beneficiaries to obtain prior authorization from their physicians before obtaining prescriptions for the acid reflux treatment Nexium, the Burlington Free Press reports. According to the Free Press, the move illustrates the “state’s strategy to curb the growth in the cost of prescription […]
No Comments »
Posted by john on June 20th, 2006 — in Nexium Top News
MONTPELIER, Vt. — The acid reflux-fighting drug Nexium has been taken off the state’s preferred drug list for Medicaid patients as officials seek to slow the rapid rise in costs for prescription drugs.
The heavily advertised “purple pill,” made by AstraZeneca, will not be available to patients under the publicly funded health care system unless their […]
No Comments »
Posted by john on June 14th, 2006 — in Nexium Top News
LONDON, June 14 (Reuters) - Global pharmaceutical sales grew 5 percent in the 12 months to April in leading markets, the same rate recorded a month earlier, healthcare information company IMS Health said on Wednesday.
Sales through retail pharmacies in 13 leading markets, which account for more than two-thirds of the world market, totalled $371 […]
No Comments »
Posted by john on June 11th, 2006 — in Nexium Top News
CHARLESTON - A Kanawha County couple is suing the doctor it hired for serious heartburn treatment.
David and Marlene Walker filed a lawsuit June 1 in Kanawha Circuit Court against South Charleston doctor Paul Dean Kyer.
They say he botched David Walker’s treatment for gastroesophogeal reflux disease, more commonly known as “GERD.”
The lawsuit alleges Kyer attempted to […]
No Comments »
Posted by john on June 8th, 2006 — in Nexium Top News
Two AstraZeneca drugs were among the five prescription medicines most heavily advertised to U.S. consumers last year, according to a ranking compiled by Bloomberg News.
The U.K.-based drug maker, whose U.S. headquarters is in Fairfax, spent $203.5 million in 2005 on television, radio, print and billboard advertisements for its Nexium acid-reflux medication and $155.9 million in […]
No Comments »
Posted by john on June 5th, 2006 — in Nexium Top News
LOS ANGELES, California, May 23 /PRNewswire/ —
- For Non-US Health Professional Press Only
Results from a new large-scale study, presented at Digestive Disease Week (DDW) today, show that taking Nexium(R) (esomeprazole) in addition to low dose aspirin therapy significantly reduces the incidence of gastric and duodenal ulcers in patients at risk.[1] Treatment with Nexium(R) […]
No Comments »
Posted by john on June 3rd, 2006 — in Nexium Top News
(RTTNews) - AstraZeneca plc (AZN | charts | news | PowerRating), a London-based pharmaceutical company, said on Monday that results of a 12-month study revealed the proton pump inhibitor NEXIUM maintained normal gastric acid levels in patients with Zollinger- Ellison syndrome or idiopathic gastric acid hypersecretion.
NEXIUM, under investigation for Zollinger-Ellison syndrome, is indicated for […]
No Comments »
Posted by john on June 1st, 2006 — in Nexium Top News
LOS ANGELES — A new clinical study shows that the proton pump inhibitor (PPI) NEXIUM® (esomeprazole magnesium) maintained normal gastric (stomach) acid levels in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion (IGH). Results of the 12-month, multicenter study were presented at the annual Digestive Disease Week (DDW) conference. NEXIUM is indicated for the […]
No Comments »